Esophageal cancer
Conditions
Interventions
Locally advanced esophageal cancer patients receiving neoadjuvant chemotherapy combined with immunotherapy:None
Sponsors
The Second Xiangya Hospital of Central South University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with histologically confirmed esophageal cancer by biopsy; 2. Patients recommended for neoadjuvant chemotherapy combined with immunotherapy after multidisciplinary team (MDT) consultation or evaluation by thoracic surgery experts; 3. Patients who underwent neoadjuvant chemotherapy combined with immunotherapy at our center; 4. Availability of complete imaging data at our center before and after neoadjuvant treatment.
Exclusion criteria
Exclusion criteria: 1. Patients who were deemed surgically operable by thoracic surgeons at our center but refused surgery; 2. Patients with missing or poor-quality CT imaging data; 3. Patients with concurrent malignancies; 4. Patients with incomplete clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative successful resection;Pathological complete response (pCR); | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence status; | — |
Countries
China
Contacts
Public ContactHe Xue
The Second Xiangya Hospital of Central South University
Outcome results
None listed